Antiviral Activity and Mode of Action of TMC647078, a Novel Nucleoside Inhibitor of the Hepatitis C Virus NS5B Polymerase

Chronic infection with hepatitis C virus (HCV) is a major global health burden and is associated with an increased risk of liver cirrhosis and hepatocellular carcinoma. Current therapy for HCV infection has limited efficacy, particularly against genotype 1 virus, and is hampered by a range of advers...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Berke, Jan Martin, Vijgen, Leen, Lachau-Durand, Sophie, Powdrill, Megan H., Rawe, Svea, Sjuvarsson, Elena, Eriksson, Staffan, Götte, Matthias, Fransen, Els, Dehertogh, Pascale, Van den Eynde, Christel, Leclercq, Laurent, Jonckers, Tim H. M., Raboisson, Pierre, Nilsson, Magnus, Samuelsson, Bertil, Rosenquist, Åsa, Fanning, Gregory C., Lin, Tse-I
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 2011
Matèries:
Antiviral Agents
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3147651/
https://ncbi.nlm.nih.gov/pubmed/21576430
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00214-11
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars